3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27
Leukemia
23
Prostatic Neoplasms
12
Lymphoma
11
Burkitt Lymphoma
9
Lymphoma, Large B-Cell, Diffuse
4
Myelodysplastic Syndromes
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large-Cell, Immunoblastic
3
Leukemia, Myeloid, Acute
3
Leukemia, Biphenotypic, Acute
3
Dendritic Cell Sarcoma, Interdigitating
3
Anemia, Refractory, with Excess of Blasts
3
Recurrence
2
Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Hodgkin Disease
2
Anemia, Refractory
2
Stomatitis
1
Rhabdoid Tumor
1
Pituitary Neoplasms
1
Pituitary Diseases
1
Pancreatic Neoplasms
1
Oral Ulcer
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Myeloproliferative Disorders
1
Interventions
Doxorubicin
11
Razoxane
5
Dexrazoxane
5
Electrocardiography
4
Echocardiography
4
Cyclophosphamide
4
Vincristine
3
Trastuzumab
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Exercise
3
Etoposide
3
Carvedilol
3
Radiotherapy
2
Prednisone
2
Methotrexate
2
Magnetic Resonance Spectroscopy
2
Bleomycin
2
salicylhydroxamic acid
1
oblimersen
1
hydrocortisone hemisuccinate
1
dapagliflozin
1
Vascular Stiffness
1
VAP-cyclo protocol
1
Tablets
1
Silymarin
1
Reverse Transcriptase Polymerase Chain Reaction
1
Resistance Training
1
Pulse Wave Analysis
1
Palliative Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cardiotoxicity
×
Hydrocortisone
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled